Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

WHS Findings Back Expanded Aspirin Professional Labeling – Bayer

This article was originally published in The Tan Sheet

Executive Summary

Results from the Women's Health Study showing the effects of aspirin therapy in women support Bayer Consumer Care's citizen petition requesting expanded professional labeling, the firm says

You may also be interested in...



CHARISMA May Make Bayer Primary MI Prevention Petition More Popular

Bayer's bid for an indication for the primary prevention of MI on professional aspirin labeling may be strengthened by data from the CHARISMA trial

CHARISMA May Make Bayer Primary MI Prevention Petition More Popular

Bayer's bid for an indication for the primary prevention of MI on professional aspirin labeling may be strengthened by data from the CHARISMA trial

CHARISMA May Make Bayer Primary MI Prevention Petition More Popular

Bayer's bid for an indication for the primary prevention of MI on professional aspirin labeling may be strengthened by data from the CHARISMA trial

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS098522

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel